1 I. Mazzetta, "Wearable Sensors System for an Improved Analysis of Freezing of Gait in Parkinson’s Disease Using Electromyography and Inertial Signals" 19 (19): 948-, 2019
2 E. Jaakkola, "Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson’s disease" 24 (24): 1341-1347, 2017
3 N. Ramsay, "Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson’s disease" 76 : 49-53, 2020
4 S. Kumar, "Tremor and Rigidity in Patients with Parkinson’s Disease : Emphasis on Epidemiology, Pathophysiology and Contributing Factors" 21 (21): 596-609, 2022
5 S. Sveinbjornsdottir, "The clinical symptoms of Parkinson’s disease" 139 (139): 318-324, 2016
6 H. Hasan, "Technologies Assessing Limb Bradykinesia in Parkinson’s Disease" 65-77, 2017
7 H. -Y. Chu, "Synaptic and cellular plasticity in Parkinson’s disease" 41 (41): 447-452, 2020
8 C. Chattoraj, "Robotic Assistance in Locomotive Health Recovery : A review" 3 (3): 10-19, 2023
9 J. Zhang, "Revisiting the Medical Management of Parkinson’s Disease:Levodopa versus Dopamine Agonist" 14 (14): 356-363, 2016
10 G. Abbruzzese, "Rehabilitation for Parkinson’s disease:Current outlook and future challenges" S60-S64, 2016
1 I. Mazzetta, "Wearable Sensors System for an Improved Analysis of Freezing of Gait in Parkinson’s Disease Using Electromyography and Inertial Signals" 19 (19): 948-, 2019
2 E. Jaakkola, "Ventral striatal dopaminergic defect is associated with hallucinations in Parkinson’s disease" 24 (24): 1341-1347, 2017
3 N. Ramsay, "Validation of a UPDRS-/MDS-UPDRS-based definition of functional dependency for Parkinson’s disease" 76 : 49-53, 2020
4 S. Kumar, "Tremor and Rigidity in Patients with Parkinson’s Disease : Emphasis on Epidemiology, Pathophysiology and Contributing Factors" 21 (21): 596-609, 2022
5 S. Sveinbjornsdottir, "The clinical symptoms of Parkinson’s disease" 139 (139): 318-324, 2016
6 H. Hasan, "Technologies Assessing Limb Bradykinesia in Parkinson’s Disease" 65-77, 2017
7 H. -Y. Chu, "Synaptic and cellular plasticity in Parkinson’s disease" 41 (41): 447-452, 2020
8 C. Chattoraj, "Robotic Assistance in Locomotive Health Recovery : A review" 3 (3): 10-19, 2023
9 J. Zhang, "Revisiting the Medical Management of Parkinson’s Disease:Levodopa versus Dopamine Agonist" 14 (14): 356-363, 2016
10 G. Abbruzzese, "Rehabilitation for Parkinson’s disease:Current outlook and future challenges" S60-S64, 2016
11 A. Vieira de Moraes Filho, "Progressive Resistance Training Improves Bradykinesia, Motor Symptoms and Functional Performance in Patients with Parkinson’s Disease" 15 : 87-95, 2020
12 Y. J. Zhao, "Progression of Parkinson’s disease as evaluated by Hoehn and Yahr stage transition times" 25 (25): 710-716, 2010
13 J. J. Crouse, "Postural instability and falls in Parkinson’s disease" 27 (27): 549-555, 2016
14 A. H. Snijders, "Physiology of freezing of gait" 80 (80): 644-659, 2016
15 D. L. M. Radder, "Physical therapy and occupational therapy in Parkinson’s disease" 127 (127): 930-943, 2017
16 D. G. Rutz, "Physical Therapy for Freezing of Gait and Gait Impairments in Parkinson Disease : A Systematic Review" 12 (12): 1140-1156, 2020
17 M. S. Islam, "Pesticides and Parkinson’s disease: Current and future perspective" 115 : 101966-, 2021
18 C. Raza, "Parkinson’s disease: Mechanisms, translational models and management strategies" 226 : 77-90,
19 D. Fredericks, "Parkinson’s disease and Parkinson’s disease psychosis: a perspective on the challenges, treatments, and economic burden" 23 (23): 83-92, 2017
20 B. R. Bloem, "Parkinson’s disease" 397 (397): 2284-2303, 2021
21 M. T. Hayes, "Parkinson’s Disease and Parkinsonism" 132 (132): 807-7201, 2019
22 E. R. Foster, "Occupational Therapy Interventions for Instrumental Activities of Daily Living for Adults with Parkinson’s Disease: A Systematic Review" 75 (75): 7503190030-, 2021
23 R. F. Pfeiffer, "Non-motor symptoms in Parkinson’s disease" 22 (22): 119-122, 2016
24 J. Opara, "Motor assessment in Parkinson`s disease" 24 (24): 411-415, 2017
25 G. Bonassi, "Mirror Visual Feedback to Improve Bradykinesia in Parkinson’s Disease" e8764238-, 2016
26 M. Guo, "Microglial exosomes facilitate α-synuclein transmission in Parkinson’s disease" 143 (143): 1476-1497, 2020
27 D. A. Bennett, "Metric properties of nurses’ ratings of parkinsonian signs with a modified Unified Parkinson’s Disease Rating Scale" 49 (49): 1580-1587, 1997
28 M. K. Mak, "Long-term effects of exercise and physical therapy in people with Parkinson disease" 13 (13): 11-, 2017
29 M. Senek, "Levodopa-entacapone-carbidopa intestinal gel in Parkinson’s disease : A randomized crossover study" 32 (32): 283-286, 2017
30 S. Y. H. Lee, "Inflammatory Mechanisms in Parkinson’s Disease: From Pathogenesis to Targeted Therapies" 28 (28): 485-506, 2022
31 J. Pérez-Pérez, "Head-to-Head Comparison of the Neuropsychiatric Effect of Dopamine Agonists in Parkinson’s Disease: A Prospective, Cross-Sectional Study in Non-demented Patients" 32 (32): 401-407, 2015
32 P. -L. Zhang, "Genetics of Parkinson’s disease and related disorders" 55 (55): 73-80, 2018
33 A. Mirelman, "Gait impairments in Parkinson’s disease" 18 (18): 697-708, 2019
34 J. Nonnekes, "Freezing of gait: a practical approach to management" 14 (14): 768-778, 2015
35 E. R. Foster, "Feasibility of a cognitive strategy training intervention for people with Parkinson’s disease" 40 (40): 1127-1134, 2018
36 N. A. Gouda, "Emerging Therapeutic Strategies for Parkinson’s Disease and Future Prospects: A 2021 Update" 10 (10): 371-, 2022
37 K. Gordt, "Effects of Wearable Sensor-Based Balance and Gait Training on Balance, Gait, and Functional Performance in Healthy and Patient Populations : A Systematic Review and Meta-Analysis of Randomized Controlled Trials" 64 (64): 74-89, 2018
38 J. Y. Y. Kwok, "Effects of Mindfulness Yoga vs Stretching and Resistance Training Exercises on Anxiety and Depression for People with Parkinson Disease: A Randomized Clinical Trial" 76 (76): 755-763, 2019
39 C. L. H. Chung, "Effectiveness of resistance training on muscle strength and physical function in people with Parkinson’s disease: a systematic review and meta-analysis" 30 (30): 11-23, 2016
40 M. J. Armstrong, "Diagnosis and Treatment of Parkinson Disease: A Review" 323 (323): 548-560, 2020
41 A. Tarakad, "Diagnosis and Management of Parkinson’s Disease" 37 (37): 118-126, 2017
42 N. Malek, "Deep Brain Stimulation in Parkinson’s Disease" 67 (67): 968-978, 2019
43 P. Alves Da Rocha, "Complementary physical therapies for movement disorders in Parkinson’s disease: a systematic review" 51 (51): 693-704, 2015
44 S. Y. Kang, "Characteristics of the sequence effect in Parkinson’s disease" 25 (25): 2148-2155, 2010
45 Hiroshi Kataoka ; Yohei Okada ; Takao Kiriyama ; Yorihiro Kita ; Junji Nakamura ; Shu Morioka ; Koji Shomoto ; Satoshi Ueno, "Can Postural Instability Respond to Galvanic Vestibular Stimulation in Patients with Parkinson’s Disease?" 대한파킨슨병및이상운동질환학회 9 (9): 40-43, 2016
46 S. Rinalduzzi, "Balance Dysfunction in Parkinson’s Disease" 2015 : e434683-, 2015
47 R. Cano-de-la-Cuerda, "Axial rigidity and quality of life in patients with Parkinson’s disease : a preliminary study" 20 (20): 817-823, 2011
48 A. Mirelman, "Arm swing as a potential new prodromal marker of Parkinson’s disease" 31 (31): 1527-1534, 2016
49 J. F. Baizabal-Carvallo, "Anti-Gravity Treadmill Training for Freezing of Gait in Parkinson’s Disease" 10 (10): 2020
50 J. G. V. Habets, "An update on adaptive deep brain stimulation in Parkinson’s disease" 33 (33): 1834-1843, 2018
51 A. Atik, "Alpha-Synuclein as a Biomarker for Parkinson’s Disease" 26 (26): 410-418, 2016
52 P. A. Kempster, "A new look at James Parkinson’s Essay on the Shaking Palsy" 69 (69): 482-485, 2007
53 P. Zham, "A Kinematic Study of Progressive Micrographia in Parkinson’s Disease" 10 : 403-, 2019